LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
25.73
-0.14 (-0.54%)
May 9, 2025, 1:29 PM - Market open
LENZ Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$41.80
Upside
+62.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +47.69% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +16.60% | Apr 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $38 → $51 | Buy | Maintains | $38 → $51 | +98.21% | Apr 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $44 → $47 | Strong Buy | Maintains | $44 → $47 | +82.67% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +47.69% | Nov 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +43.80% | Sep 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +39.91% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +47.69% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +47.69% | Aug 12, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $32 | Buy | Initiates | $32 | +24.37% | Apr 15, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +32.14% | Apr 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $28 | Buy | Initiates | $28 | +8.82% | Mar 27, 2024 |